Crinetics Pharmaceuticals ($CRNX) Insider Trading & Smart Money Activity

Crinetics Pharmaceuticals, Inc. · Biotechnology · Latest filing Jul 30, 2026

Crinetics Pharmaceuticals, Inc. ($CRNX) has 7 insider trades, 1 congress trade, 4 13F position changes and 3 analyst ratings on file. In the last 12 months on the open market, no insider bought and 1 insider sold ($246.14K), net -$246.14K.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
1
Net insider $ (12 mo)
-$246.14K
Congress trades (12 mo)
1
13F moves on file
4
Analyst ratings on file
3

CRNX insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 1 · $246.14K 0 / 0 4 / 0
Q3 2026 0 0 0 / 1 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All CRNX insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Congress Gilbert Ray Cisneros Jr. Sale $15,001 - $50,000 —
Insider Wendell Wierenga Buy (Grant or award) 9.73K sh —
Insider Vivaldi Coelho Rogerio Buy (Grant or award) 9.73K sh —
Insider Stephanie Okey Buy (Grant or award) 9.73K sh —
Insider Weston Nichols Buy (Grant or award) 9.73K sh —
Insider Matthew Fust Buy (Grant or award) 9.73K sh Read
Insider Camille Bedrosian Buy (Grant or award) 5.92K sh —
Insider Stephanie Okey Sell (Open-market sale) 10b5-1 6.90K sh $246.14K —
Analyst HC Wainwright Reiterates to buy PT $81 +0.7% Read
Analyst Citizens Reiterates to buy PT $95 +7.0% Read
Analyst Citizens Reiterates to buy PT $95 +7.0% Read
13F Rtw Investments Added +100K sh $54.31M +0.1%-4.5% Read
13F Farallon Capital Management Added +1.41M sh $312.01M +0.1%-4.5% —
13F Baker Bros. Advisors Added +702.60K sh $87.99M +0.1%-4.5% —
13F Gw&K Investment Management Added +142.36K sh $60.57M -3.2%-8.0% —

1W / 1M / 6M = how CRNX moved from the trade or filing date.

Insider trading in CRNX: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Stephanie Okey 2 -$246.14K Jun 18, 2026
Wendell Wierenga 1 — Jun 18, 2026
Vivaldi Coelho Rogerio 1 — Jun 18, 2026
Weston Nichols 1 — Jun 18, 2026
Matthew Fust 1 — Jun 18, 2026
Camille Bedrosian 1 — Jun 18, 2026

Members of Congress trading CRNX

Institutions moving CRNX (13F)

Analyst ratings on CRNX

DateFirmActionRatingPrice target1W1M6MStory
HC Wainwright Reiterates buy $81 +0.7% Read
Citizens Reiterates buy $95 +7.0% Read
Citizens Reiterates buy $95 +7.0% Read

Frequently asked questions

Are CRNX insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 1 insider made 1 open-market sale worth $246.14K, a net -$246.14K.

What is the latest insider trade in CRNX?

Wendell Wierenga filed a buy (grant or award) of 9.73K sh on Jun 18, 2026.

Which members of Congress traded CRNX?

1 disclosed trade by Gilbert Ray Cisneros Jr.. The latest was on Jul 30, 2026.

Which institutions changed their CRNX positions?

Recent 13F filers moving the stock include Rtw Investments, Farallon Capital Management, Baker Bros. Advisors and Gw&K Investment Management.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text